246 related articles for article (PubMed ID: 3530446)
1. Phase II study of carboplatin in patients with ovarian carcinoma: a National Cancer Institute of Canada Clinical Trials Group Study.
Eisenhauer EA; Swenerton KD; Sturgeon JF; Fine S; O'Reilly SE
Cancer Treat Rep; 1986 Oct; 70(10):1195-8. PubMed ID: 3530446
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of the combination paclitaxel/carboplatin in patients with previously treated advanced ovarian carcinoma: a multicenter French Groupe des Investigateurs Nationaux pour l'Etude des Cancers Ovariens phase II study.
Pujade-Lauraine E; Guastalla JP; Weber B; Curé H; Orfeuvre H; Mousseau M; Vincent P; Diéras V; Tubiana-Mathieu N; Jacquin JP; Mignot L; Leduc B; Paraïso D; Viens P
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-30-S15-35. PubMed ID: 9346219
[TBL] [Abstract][Full Text] [Related]
3. A phase I, first in man study of OSI-7836 in patients with advanced refractory solid tumors: IND.147, a study of the Investigational New Drug Program of the National Cancer Institute of Canada Clinical Trials Group.
Goss G; Siu LL; Gauthier I; Chen EX; Oza AM; Goel R; Maroun J; Powers J; Walsh W; Maclean M; Drolet DW; Rusk J; Seymour LK;
Cancer Chemother Pharmacol; 2006 Nov; 58(5):703-10. PubMed ID: 16528532
[TBL] [Abstract][Full Text] [Related]
4. Carboplatin, an active drug in advanced head and neck cancer.
de Andres Basauri L; Lopez Pousa A; Alba E; Sampedro F
Cancer Treat Rep; 1986 Oct; 70(10):1173-6. PubMed ID: 3530443
[TBL] [Abstract][Full Text] [Related]
5. Phase I clinical and pharmacologic trial of carboplatin daily for 5 days.
Van Echo DA; Egorin MJ; Whitacre MY; Olman EA; Aisner J
Cancer Treat Rep; 1984 Sep; 68(9):1103-14. PubMed ID: 6383605
[TBL] [Abstract][Full Text] [Related]
6. Phase I study of carboplatin (CBDCA) in children with cancer.
Bacha DM; Caparros-Sison B; Allen JA; Walker R; Tan CT
Cancer Treat Rep; 1986 Jul; 70(7):865-9. PubMed ID: 3521846
[TBL] [Abstract][Full Text] [Related]
7. Modulation of platinum sensitivity and resistance by cyclosporin A in refractory ovarian and fallopian tube cancer patients: a phase II study.
Chambers SK; Davis CA; Schwartz PE; Kohorn EI; Chambers JT
Clin Cancer Res; 1996 Oct; 2(10):1693-7. PubMed ID: 9816118
[TBL] [Abstract][Full Text] [Related]
8. Phase II trial of carboplatin in advanced breast carcinoma: a Cancer and Leukemia Group B Study.
Booth BW; Weiss RB; Korzun AH; Wood WC; Carey RW; Panasci LC
Cancer Treat Rep; 1985; 69(7-8):919-20. PubMed ID: 3893695
[No Abstract] [Full Text] [Related]
9. A phase I and pharmacokinetic study of diamminecyclobutane-dicarboxylatoplatinum (NSC 241240).
Curt GA; Grygiel JJ; Corden BJ; Ozols RF; Weiss RB; Tell DT; Myers CE; Collins JM
Cancer Res; 1983 Sep; 43(9):4470-3. PubMed ID: 6347373
[TBL] [Abstract][Full Text] [Related]
10. Phase II trial of carboplatin in advanced malignant melanoma.
Evans LM; Casper ES; Rosenbluth R
Cancer Treat Rep; 1987 Feb; 71(2):171-2. PubMed ID: 3542209
[TBL] [Abstract][Full Text] [Related]
11. A Phase 2 trial of the liposomal DACH platinum L-NDDP in patients with therapy-refractory advanced colorectal cancer.
Dragovich T; Mendelson D; Kurtin S; Richardson K; Von Hoff D; Hoos A
Cancer Chemother Pharmacol; 2006 Dec; 58(6):759-64. PubMed ID: 16847673
[TBL] [Abstract][Full Text] [Related]
12. Phase II study of lonidamine in patients with metastatic breast cancer: a National Cancer Institute of Canada Clinical Trials Group Study.
Band PR; Maroun J; Pritchard K; Stewart D; Coppin CM; Wilson K; Eisenhauer EA
Cancer Treat Rep; 1986 Nov; 70(11):1305-10. PubMed ID: 3768873
[TBL] [Abstract][Full Text] [Related]
13. Carboplatin/paclitaxel versus cisplatin/paclitaxel as first-line chemotherapy in advanced ovarian cancer: an interim analysis of a randomized phase III trial of the Arbeitsgemeinschaft Gynäkologische Onkologie Ovarian Cancer Study Group.
du Bois A; Lück HJ; Meier W; Möbus V; Costa S; Richter B; Warm M; Bauknecht T; Schröder W; Olbricht S; Nitz U; Jackisch C
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-44-S15-52. PubMed ID: 9346222
[TBL] [Abstract][Full Text] [Related]
14. Carboplatin therapy in advanced endometrial cancer.
Green JB; Green S; Alberts DS; O'Toole R; Surwit EA; Noltimier JW
Obstet Gynecol; 1990 Apr; 75(4):696-700. PubMed ID: 2179783
[TBL] [Abstract][Full Text] [Related]
15. [Phase II study of carboplatin in head and neck cancer].
Inuyama Y; Togawa K; Morita M; Takeoda S; Kaneko T; Takemiya S; Ono I; Nomura Y; Okuda M; Kikuchi K
Gan To Kagaku Ryoho; 1988 Jul; 15(7):2131-8. PubMed ID: 3293536
[TBL] [Abstract][Full Text] [Related]
16. ICON 2 and ICON 3 data in previously untreated ovarian cancer: results to date.
Harper P
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-23-S15-25. PubMed ID: 9346217
[TBL] [Abstract][Full Text] [Related]
17. Carboplatin plus paclitaxel as first-line chemotherapy in previously untreated advanced ovarian cancer. German AGO Study Group Ovarian Cancer. Arbeitsgemeinschaft Gynäkologische Onkologie.
du Bois A; Lück HJ; Meier W; Möbus V; Costa S; Richter B; Bauknecht T; Warm M; Schroeder W; Olbricht S; Nitz U; Jackisch C
Semin Oncol; 1997 Aug; 24(4 Suppl 11):S11-28-S11-33. PubMed ID: 9314296
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of oxaliplatin in platinum-resistant and refractory ovarian cancer: a gynecologic group study.
Fracasso PM; Blessing JA; Morgan MA; Sood AK; Hoffman JS
J Clin Oncol; 2003 Aug; 21(15):2856-9. PubMed ID: 12885801
[TBL] [Abstract][Full Text] [Related]
19. [A phase II study of carboplatin in small cell lung cancer].
Komatsu H; Furuse K; Nishikawa H; Minoda S; Saotome K; Nemoto E; Tani Y; Saito T; Ishiwata K; Tsutsumi M
Gan To Kagaku Ryoho; 1988 Aug; 15(8):2313-8. PubMed ID: 2841905
[TBL] [Abstract][Full Text] [Related]
20. Carboplatin and short-infusion paclitaxel in high-risk and advanced-stage ovarian carcinoma.
Coleman RL; Bagnell KG; Townley PM
Cancer J Sci Am; 1997; 3(4):246-53. PubMed ID: 9263631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]